Correlation Between Leap Therapeutics and GH Research

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Leap Therapeutics and GH Research at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Leap Therapeutics and GH Research into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Leap Therapeutics and GH Research PLC, you can compare the effects of market volatilities on Leap Therapeutics and GH Research and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Leap Therapeutics with a short position of GH Research. Check out your portfolio center. Please also check ongoing floating volatility patterns of Leap Therapeutics and GH Research.

Diversification Opportunities for Leap Therapeutics and GH Research

-0.1
  Correlation Coefficient

Good diversification

The 3 months correlation between Leap and GHRS is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Leap Therapeutics and GH Research PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GH Research PLC and Leap Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Leap Therapeutics are associated (or correlated) with GH Research. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GH Research PLC has no effect on the direction of Leap Therapeutics i.e., Leap Therapeutics and GH Research go up and down completely randomly.

Pair Corralation between Leap Therapeutics and GH Research

Given the investment horizon of 90 days Leap Therapeutics is expected to under-perform the GH Research. In addition to that, Leap Therapeutics is 4.08 times more volatile than GH Research PLC. It trades about -0.39 of its total potential returns per unit of risk. GH Research PLC is currently generating about 0.28 per unit of volatility. If you would invest  791.00  in GH Research PLC on November 2, 2024 and sell it today you would earn a total of  178.00  from holding GH Research PLC or generate 22.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Leap Therapeutics  vs.  GH Research PLC

 Performance 
       Timeline  
Leap Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Leap Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
GH Research PLC 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in GH Research PLC are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, GH Research unveiled solid returns over the last few months and may actually be approaching a breakup point.

Leap Therapeutics and GH Research Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Leap Therapeutics and GH Research

The main advantage of trading using opposite Leap Therapeutics and GH Research positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Leap Therapeutics position performs unexpectedly, GH Research can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GH Research will offset losses from the drop in GH Research's long position.
The idea behind Leap Therapeutics and GH Research PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets